## 

## 

## 

|Trustees|Report and General Information|Report and General Information|2-4|
|---|---|---|---|
|Auditors|Report||5-7|
|Statement|ofFinancial|Activities||
|Balance|Sheet|||
|Statement|ofCash Flows||10|
|Notes to|the Financial|Statements|ll - 16|





## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 

## 



## 

## 



## 

## 

## 

## 

## 

## 



||||||OC||||||Oc|||Vl||IO|IO|In||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||IO<br>Io|O|9||Cc<br>vl|cn"<br>cnl||||I I|Ol|Vl<br>t|t<br>VI<br>IO<br>00|I I<br>Ol<br>Ctl<br>00||00<br>Vl||00<br>00<br>CC||
||Ei<br>A||g||IO<br>IO|O|Vl<br>cn|||Ol<br>OI<br>cn|Ol<br>Ol<br>cn||t<br>Oc|VI<br>IO<br>00<br>Vl||||||
||||||||||||||Vl|||||||
||cn|RCI||||||||||||||||||
||'O4<br>Cl||||CO<br>Vl|vl<br>VI<br>CC<br>CC|IO<br>'O<br>cn|||cn<br>CC<br>Ol|t' In|O<br>CC|OC<br>IO<br>IO<br>t|cn<br>IO<br>00||cn<br>t<br>cn<br>1<br>00||||
||||||||00||||||||Vl|||||
||||||||||||||||CC|||||
||CC|+|g||||cn<br>IO<br>I I||||||||00<br>CC<br>CC|||||
||||||||1||||||||O|||||
||||||||||||||||cc|||||
||CR|||||||||||||||||||
||||||||||||||||'O||'O|||
||A||g|'+I|||||||||||Vl|||||
|||Rt||||||||||||||||||
||||||||||||||||00|||||
||'O44||||||||||||||cn<br>cn||cn|||
||||||||'O||||||||||t|||
||||||||cn||||||||||00|||
||||||||||||||||||||0|
|cn|||||||||||||||||||0|
|A||||||||||||||||||||
||||||||||||||||||||6|
||||||||||||||I||O|||||
||||||||||||||~a|~||||||
||||||||||||||||g||||~O|
||||||||||||||||||||IO|
||||||||||||||||||||O|
|||||||||||||||||t:t||O<br>~O||
|||||||e||||||||||z0|@||Cl00<br>cCO|
|||||||||||||||||d~|||O|
||||||||||||||||||||O|
|||||0g~|v||||||||CR|||8||8|O<br>Cl|
|||||t-i A|Rtt|||c|OR u 8||||z,|k||0||t||





## 

|BALANCE SHEET|||||
|---|---|---|---|---|
||||2021|2020|
||||Total|Total|
|||||f,|
|FIXED ASSETS|||||
|Investments||||14,123,523|
|CURRBNT ASSETS|||||
|Cash at bank<br>TOTALC~ASSETS||||142,724<br>142,724|
|LIABILITIES|||||
|Creditors falling due within|one year|||1,577,362|
|NET CURRENT LIABILITIES||||(1,434,638)|
|NET ASSETS||||12,688,885|
|THE FUNDS OP THE~TY|||||
|Unrestricted<br>funds||||11,847,323|
|Restricted<br>funds||||841,562|
|Total funds||10||12,688,885|





## 

## 

## 

||||||2021|2020|
|---|---|---|---|---|---|---|
|||||Note|Total|Total|
|Net cash provided<br>by/(used||in) operating|activitim|11|(1,577,362)|(390,075)|
|Cash flows from investing||activities:|||||
|Transfer offunds|||||(12,688,885)||
|Interest and dividends||||||433,216|
|Cash invested||||||(310,000)|
|Management<br>fees paid trom||capital account||||16,566|
|Transfer ofinvestments|||||14,123,523||
|Net cash provided<br>by/(used||in) investing|activities||1,434,638|139,782|
|Change in cash and cash equivalents|||||||
|in the reporting<br>period|||||(142,724)|(250,293)|
|Cash and cash equivalents|at the||||||
|beginning<br>ofthe reporting||period|||142,724|393,017|
|Cash and cash equivalents|at the||||||
|end ofthe reporting<br>period||||||142,724|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

|||Unrestricted|Restricted|Total|
|---|---|---|---|---|
|BEQUESTS AND GRANTS<br>Year ended 31stDecember 2021||Funds|Funds<br>I|Funds|
|Legacy||1,736,948||1,736,948|
|||Unrestricted|Restricted|Total|
|Year ended 31stDecember 2020||Funds|Funds|Funds I|
|Ion Moulton Foundation|Grant||124,400|124,400|
|Rosetrees||32,560||32,560|
|||32,560|]24,400|]56,960|
|INVESTMENT INCOME|||2021|2020|
|Listed UK investments||||432,980|
|Interest on cash deposits||||236|
|||||433,216|





## 

## 

## 

|NOTES|TO THE FINANCIAL STATEMENTS|TO THE FINANCIAL STATEMENTS||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|4)|CHARITABLE ACTIVITIES||||||Charitable|Support<br>and<br>Governance||||
||||||||Activities||Costs||Total|
||Year ended 31st December|2021||||||||I||
||Transfer to BMA Foundation||||||1,736,948||||1,736,948|
|||||||||Supportand||||
||||||||Charitable|Governance||||
||||||||Charitable|Governance||||
||||||||Activities||Costs||Total|
||Year ended 31st December|2020||||||||||
||Grants (see note 6)<br>Bank charges<br>Accountancy<br>Audit fee||||||541,824||88<br>4,781<br>2,868||541,824<br>88<br>4,781<br>2,868|
||Recharged<br>salaries<br>Miscellaneous||||||||96,786<br>35||96,786<br>35|
||||||||541,824||104,558||646,382|
|5)|AUDITORS' REMUNERATION<br>The auditors'<br>remuneration<br>constituted|||an audit fee|offNil (2020:62,868)||and management||accounts||fees|
||and tax work of8500 (2020; f4,781).|||||||||||
||ANALYSIS OF GRANTS|||||||||||
||This is made up ofgrant commitments|||to institutions|analysed|as foUows:||||202]|2020|
||TP Gunton|||||||||||
||2020 - Dr BDavies||||||||||57,207|
||Helen H Lawson|||||||||||
||2020 —Dr T Waterftetd||||||||||49,200|
||Josephine<br>LansdeU<br>2020 - Dr TPatterson||||||||||64,076|
||Vera Down|||||||||||
||2020 - Dr SRinaldi||||||||||64,955|
||Kathleen Harper<br>2020 - Dr A Hammond||||||||||57,539|
||Doris Hillier|||||||||||
||2020 - Dr P Riches||||||||||50,857|
||Scholarship<br>Trust<br>2020 - Professor A Grant||||||||||64,800|
||JMoulton|||||||||||
||2020 - Dr A Al-Hindawi||||||||||61,109|
||2020<br>—Dr RBrown||||||||||63,290|
||Lift into Research|||||||||||
||2020 - Dr K Fairhurst||||||||||20,000|
||2020 - Dr H Al Hassan||||||||||20,000|
||2020 - Mr C Hannan||||||||||20,000|
||Other grants<br>and prizes<br>Adjustment<br>for grants unclaimed||(prior years)||||||||(51,209)|
||||||||||||541,824|





## 

## 

## 

## 

## 

|INVESTMENTS|||2021|2020|
|---|---|---|---|---|
|Market value at 1st January 2021|||13,950,559|14,023,788|
|Additions||||1,448,016|
|Disposals||||(704,674)|
|Net realised (losses)/gains||||(64,759)|
|Net unrealised<br>(losses)/gains||||(751,812)|
|Transfer to BMA Foundation|||(13,950,559)||
|Market value at 31stDecember 2021||||13,950,559|
|Historical cost at 31stDecember 2021||||10,274,089|
||Cost||Market|Value|
||2021|2020|2021|2020|
|Listed equity investments||10,274,089||13,950,559|
|||10,274,089||13,950,559|
|Cash held at brokers||172,964||172,964|
|||10,447,053||14,123,523|



## 

|CREDITORS||2021|2020|
|---|---|---|---|
|||Due within|Due within|
|||one year|one year|
|Grant comnutments|outstanding||1,546,400|
|Accruals|||30,962|
||||1,577,362|





## 

## 

## 

|NOTES|TO THE FINANCIAL<br>STATEMENTS||||||
|---|---|---|---|---|---|---|
|10)|ANALYSIS OF FUNDS -2021|||Transfer to<br>BMA|||
|||||Balance b/f|Foundation|Balance c/f|
||RESTRICTED FUNDS|||8|f,||
||Funds supporting<br>long term grants:<br>The Trump Estate<br>Walter Jobson Horne Prize Fund|||825,009<br>4,381|(825,009)<br>(4,381)||
||MedFASH|||10,070|(10,070)||
||Short term project grants:<br>Jon Moulton<br>Foundation|||2,102|(2,102)||
||Total restricted<br>funds|||841,562|(841,562)||
||Unrestricted<br>funds|||11,847,323(11,847,323)|||
||Total funds|||12,688,885 (12 688 885)|||
||ANALYSIS OF FUNDS -2020||Net Investment,||||
||||Income,|Grants<br>and|||
|||Balance b/f|Gains/(Losses)|Bequests|Expenditure|Balance c/f|
||RESTRICTED FUNDS||||||
||Funds supporting<br>long term grants:<br>The Trump Estate<br>Walter Jobson Horne Prize Fund|846,706<br>6,862|(21,697)<br>(2,481)|||825,009<br>4,381|
||MedFASH|10,341|(271)|||10,070|
||Short term project grants:<br>Jon Moulton Foundation|3,458|(1,357)|124,400|(124,399)|2,102|
||Total restricted<br>funds|867,367|(25,806)|124,400|(124,399)|841,562|
||Unrestricted<br>funds|12,710,843|(357,549)|32,560|(538,531)|11,847,323|
||Total funds|13,578,210|(383,355)|156,960|(662,930)|12,688,885|
|||||Unrestricted|Restricted||
|||||Funds|Funds|Total|
|||||||8|
||REPRESENTED BY:||||||
||Investments|||13276 112|847,411|14,123,523|
||Cash at bank|||142,724||142,724|
||Creditors|||(1,571,513)|(5,849)|(1,577,362)|
|||||11,847,323|841,562|12,688,885|





## 

## 

## 

## 

|RECONCILIATION<br>OF INCOME T<br>ACTIVITIES|O NET CASH FLOW FROM O|PERATING||
|---|---|---|---|
|||2021|2020|
|||8||
|Net income for the reporting<br>period (as per page 8 - SOFA)|||(889,325)|
|Adjustments<br>for:<br>Dividends<br>and interest from investments|||(433,216)|
|(Gains)/losses<br>on investments<br>(Increase)/decrease<br>in debtors<br>Increase/(decrease)<br>in creditors||(1,577,362)|816,571<br>680<br>115,215|
|Net cash provided<br>by/(used<br>in) operating|activities|(1,577,362)|(390,075)|
|ANALYSIS OF CASH AND CASH EQUIVALENTS||2021|2020|
|Cash at bank|||142,724|



